Jon Rousseau

Chairman, President, and Chief Executive Officer at BrightSpring Health Services

Board

Since September 2016

Age

50 years

Education

Earned an MBA from Harvard Business School and an A.B. degree from Princeton University.

Tenure

Joined in September 2016 as President and Chief Executive Officer and became Chairman of the board in January 2024.

Also at BrightSpring Health Services

Bob Barnes

President of Community Living

Jennifer Phipps

Chief Financial Officer (CFO)

Jennifer Yowler

President of PharMerica

About

Jon Rousseau is the Chairman, President, and Chief Executive Officer at BrightSpring Health Services, Inc. His leadership started when he joined in September 2016 as President and CEO, a role in which he has driven significant strategic initiatives and operational growth.

His extensive professional background includes senior roles at Kindred Healthcare, where he served in multiple leadership capacities, as well as impactful positions in companies such as Mylan, Inc. and Medtronic PLC. This diverse experience in the healthcare industry has been a key asset in guiding the company.

Before his roles in healthcare, he built a solid foundation in finance by working in private equity and investment banking, experiences that enriched his analytical and strategic capabilities. His academic credentials, which include an MBA from Harvard Business School and an A.B. degree from Princeton University, further complement his extensive career in the industry.

$BTSG Performance Under Jon Rousseau

Past Roles

Organization	Role	Date Range
Optum Inc. (UnitedHealth Group)	Executive Vice President	N/A [N/A]

Fixed Compensation

Data from FY 2023

Component Name	Amount ($)	Payment Schedule	Additional Details
Base Salary	926,027	Annual	Includes salary increase effective May 16, 2023, raised from $800,000 to $1,000,000.
Health Insurance Premiums	1,687	Annual	Cost of health insurance premiums for 2023.
Use of Private Plane	51,522	As Incurred	Cost associated with private plane usage.
Stock Option Cancellation Payment	10,000,000	Lump Sum (November 2023)	Cash payment for cancellation of 628,108 stock options: $3,437,500 for 215,912 shares held directly and $6,562,500 for 412,196 shares held in an irrevocable trust.
Health & Welfare Benefits	22,538	Annual (Coverage for 18 months)	Estimated COBRA medical insurance cost under 2023 rates for 18 months.

Performance Compensation

Data from FY 2023

Annual Cash Incentive Award (BHS STIC) for 2023

Metric/Detail	Value
Performance Metrics & Weighting	EBITDA: 50%, Quality & People: 30%, Efficiency: 10%, Revenue Growth: 10%
Threshold Achievement	91% of target (payout: 5% of target award)
Target Achievement	100% of target (payout: 100% of target award)
Maximum Achievement	120% of target (payout: 200% of target award)
Minimum EBITDA Trigger	90% (required for plan funding)
Grant Date	May 11, 2023
Payout Amounts	Threshold: $31,250, Target: $1,250,000, Maximum: $2,500,000
Actual Outcome	Payout earned: $1,419,531 (114% of target award)

Long-Term Equity Awards (2023 Grant Stock Options)

Metric/Detail	Value
Grant Date	November 22, 2023
Grant Date Fair Value	$5,949,200
Exercise Price	$22.29 per share
Vesting Schedule	If no IPO within six months: 100% vest on the six-month anniversary; if IPO occurs within six months: one-third at six months with remaining vesting monthly over two years
Term	10 years
Performance Metrics/Targets	Not specified; vesting is time-based and contingent on corporate events

Performance-Vesting Stock Options (2019 Grant)

Metric/Detail	Value
Grant Date	October 16, 2019
Exercise Price	$6.37 per share
Vesting Conditions	Vest when KKR Stockholder receives cash proceeds at 2.0x or 2.5x multiples on its investment
Expiration Date	October 16, 2029
Additional Performance Metrics/Targets	Specific performance thresholds not provided for 2023

Severance Payments (Performance-Based)

Metric/Detail	Value/Details
Triggering Conditions	Termination without cause, resignation for good reason, or non-renewal of the employment term
Payout Structure	Entitles Jon Rousseau to 2.0x his base salary and target incentive bonus, payable over two years
Performance Linkage	Bonus is pro-rated based on actual performance for the year of termination
Additional Vesting Details	Unvested 2023 stock options become fully vested upon termination

*All values and details are based on the 2023 data provided in the documents. *